Singapore: HSA Introduces Change Management Program (CMP) for SaMD, Including Machine-Learning Enabled SaMD January 16, 2025
Singapore: Consultation on draft of Guidance on Change Management Program (CMP) for SaMD September 4, 2024
Singapore: HSA’s Registration Approvals Recognised by Hong Kong MDD for Class II / III / IV Listing in Hong Kong May 14, 2024
Singapore: Updates To Cybersecurity Labelling Scheme For Medical Devices [CLS(MD)] Sandbox April 24, 2024
Vietnam: Decision on the Criteria and Principles for the ASEAN CSDT Assessment of Non-In Vitro and In-Vitro Medical Devices April 3, 2024
Singapore: HSA Regulations Alignment Related With Software / Programmed or Programmable Medical Device March 26, 2024
Singapore: HSA Warns On Cybersecurity Vulnerabilities Potentially Affecting Medical Devices Using 5G Modems January 3, 2024
Singapore: HSA Shares Revisions on Change Notification Guidelines Following EU MDR and IVDR Changes December 13, 2023
Singapore: Public Comments on Revised Draft of GN-20: Guidance on Clinical Evaluation November 8, 2023
